These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 169637)

  • 1. [Case of probable central nervous system cytomegaly developing in the course of long-term immunosuppressive treatment].
    Marks E; Zuzewicz W; Wolska E
    Wiad Lek; 1975 Aug; 28(15):1325-8. PubMed ID: 169637
    [No Abstract]   [Full Text] [Related]  

  • 2. Iatrogenic modification of tissue responses to infectious agents in the central nervous system.
    Bailey OT; Wolf A; Schneck SA; Rorke LB
    Res Publ Assoc Res Nerv Ment Dis; 1968; 44():445-62. PubMed ID: 4307813
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytomegalic ulcer in the caecum after renal transplantation (author's transl)].
    Clavadetscher P; Sulser H; Linder E; Deyhle P
    Dtsch Med Wochenschr; 1974 Oct; 99(40):1970-2. PubMed ID: 4369529
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytomegalovirus infections after renal transplant].
    Solá R; Caralps A; Andreu J; Ricart MJ; Brulles A; Vilardell J; Oppenheimer F; Gil Vernet JM; Beltrán M
    Rev Clin Esp; 1980 Dec; 159(5):349-54. PubMed ID: 6261312
    [No Abstract]   [Full Text] [Related]  

  • 5. [Virus infections in man during immunodepression (author's transl)].
    Bricout F; Huraux JM; Nicolas JC; Bogossian M; Descamps P
    Pathol Biol (Paris); 1976 Feb; 24(2):127-31. PubMed ID: 179044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus retinitis: two cases occurring after renal transplantation.
    Carson S; Chatterjee SN
    Ann Ophthalmol; 1978 Mar; 10(3):275-9. PubMed ID: 207209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy of cytomegalovirus infection prevention in renal transplantation.
    Legendre C; Rouzioux C; Ducloux D; Delamarre C; Chkoff N; Thervet E; Page B; Kreis H
    Adv Nephrol Necker Hosp; 1994; 23():331-45. PubMed ID: 8154363
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ocular symptoms in cytomegalovirus infection].
    Dyszyńska-Rościszewska B; Dróbecka-Brydakowa E; Moszczyńska-Kowalska A; Szreterowa M; Rowińska D
    Klin Oczna; 1988 Nov; 90(11):391-2. PubMed ID: 2855745
    [No Abstract]   [Full Text] [Related]  

  • 9. New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation.
    Simmons RL; Canafax DM; Fryd DS; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):76-81. PubMed ID: 3008390
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytomegalovirus and cytomegaly. A review and a preliminary report of our results].
    Andersen K; Freundt EA
    Ugeskr Laeger; 1968 Oct; 130(44):1849-53. PubMed ID: 4303383
    [No Abstract]   [Full Text] [Related]  

  • 11. The incidence of cytomegalovirus infection in kidney recipients.
    Cuhadaroğlu S; Tokyay R; Velidedeoğlu E; Haberal M
    Transplant Proc; 1992 Oct; 24(5):1924-5. PubMed ID: 1329288
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary cytomegalovirus infection and hepatitis in a renal allograft recipient.
    Foster KM; Ralston M; Field PR; Hayes JM; Lord RS
    Aust N Z J Med; 1972 May; 2(2):148-52. PubMed ID: 4342441
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylaxis for cytomegalovirus in pancreas transplant recipients using intravenous ganciclovir.
    Kohli V; Velosa J; Sterioff S; Munn SR
    Transplant Proc; 1995 Dec; 27(6):2993. PubMed ID: 8539806
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytomegalovirus prophylaxis in antibody-treated renal transplanted patients.
    Birkeland S; Gahrn-Hansen B; Andersen H; Rohr N; Larsen KE; Jørgensen A
    Transplant Proc; 1995 Dec; 27(6):3473-6. PubMed ID: 8540056
    [No Abstract]   [Full Text] [Related]  

  • 15. CMV management in a post-kidney-transplant child.
    Elshihabi I
    Transplant Proc; 1994 Feb; 26(1):131. PubMed ID: 8108907
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal allograft function and cytomegaly.
    Jirka J; Horcicková M; Reneltová I; Rossmann P; Seeman J; Holá V; Kocandrle V
    Proc Eur Dial Transplant Assoc; 1980; 17():407-12. PubMed ID: 6264421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OKT3 monoclonal antibody therapy and visual loss.
    Horina JH; Horn S; Holzer H; Langmann G
    Nephrol Dial Transplant; 1996 Jul; 11(7):1497-8. PubMed ID: 8815436
    [No Abstract]   [Full Text] [Related]  

  • 18. Recovery from CMV esophagitis after allogeneic bone marrow transplantation using non-myeloablative conditioning: the role of immunosuppression.
    Fiegl M; Gerbitz A; Gaeta A; Campe H; Jaeger G; Kolb HJ
    J Clin Virol; 2005 Nov; 34(3):219-23. PubMed ID: 16129661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible acute renal failure caused by the combined use of foscarnet and cyclosporin in organ transplanted patients.
    Morales JM; Muñoz MA; Fernández Zataraín G; García Cantón C; García Rubiales MA; Andrés A; Aguado JM; Gonzalez Pinto I
    Nephrol Dial Transplant; 1995; 10(6):882-3. PubMed ID: 7566623
    [No Abstract]   [Full Text] [Related]  

  • 20. Congenital cytomegalovirus infection after recurrent infection in a mother with a renal transplant.
    Blau EB; Gross JR
    Pediatr Nephrol; 1997 Jun; 11(3):361-2. PubMed ID: 9203194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.